ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 59 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,017 | -15.1% | 22,951 | -47.6% | 0.00% | – |
| Q2 2023 | $45,950 | -53.5% | 43,762 | -46.8% | 0.00% | – |
| Q1 2023 | $98,780 | +1.8% | 82,317 | +27.3% | 0.00% | – |
| Q4 2022 | $97,024 | -77.9% | 64,682 | -54.0% | 0.00% | – |
| Q3 2022 | $440,000 | -67.5% | 140,464 | -66.0% | 0.00% | – |
| Q2 2022 | $1,353,000 | +673.1% | 412,564 | +976.5% | 0.00% | – |
| Q1 2022 | $175,000 | +4.8% | 38,323 | +66.7% | 0.00% | – |
| Q4 2021 | $167,000 | – | 22,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |